Publications
107
Citations
3,501
Est. group size
—
Recurring co-author estimate
Active years
20
Publishing since 2007
This researcher studies fluid-based biomarkers (measured in blood and cerebrospinal fluid) and brain imaging markers for Alzheimer's disease and related neurodegenerative disorders, including dementia and Lewy body diseases. The work spans large-scale proteomics (protein profiling), genetic and environmental influences on brain waste-clearance systems (the glymphatic system), and the use of these biomarkers as outcome measures in clinical trials. Some work also touches on palliative care outcomes in cancer patients and traumatic brain injury biomarkers.
Publication output has grown substantially over the last decade, rising from about 1 paper per year in 2017 to a peak of 16 in 2025, averaging nearly 11 publications per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Deep learning enhanced ALPS reveals genetic and environmental factors of brain glymphatic function
EBioMedicine · 2026
- Early syndecan-4 upregulation predicts cognitive and pathological trajectories in Alzheimer disease
Alzheimer s Research & Therapy · 2026
- Large-scale CSF and plasma proteomics reveal immune, synaptic, and extracellular matrix disruptions across neurodegenerative diseases
Neuron · 2026
- Prevalence and predictors of do-not-resuscitate orders among advanced cancer patients receiving palliative care at a tertiary cancer center in Jordan: a 10-year retrospective analysis
BMC Palliative Care · 2026
- Low overlap of plasma and CSF protein quantitative trait loci affects protein discovery for neurological disease
Science Translational Medicine · 2026
- Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuum
Neuron · 2025
- Blood-based biomarkers suggest prolonged axonal Injury following pediatric mild traumatic brain injury
Scientific Reports · 2025
- Fluid Markers of Alzheimer Disease
2025
- Disentangling the Clinical and Neuroimaging Spectrum of Neuronal α-Synucleinopathies
Neurology · 2025
- Imaging Markers of Amyloid and Tau in Alzheimer Disease
2025
- Fluid and Imaging Markers of Synaptic Injury
2025
- Biomarkers as Outcome Measures in Clinical Trials of Alzheimer Disease
2025
- Fluid Markers of Brain Endothelial Injury
2025
- Plasma biomarkers in neuropsychiatric syndromes: A narrative review
Journal of Alzheimer s Disease · 2025
- CSF proteomics identifies early changes in autosomal dominant Alzheimer’s disease
Cell · 2024
- Figshare×12
- Neurology×6
- Proceedings of the National Academy of Sciences×5
- Brain×5
- Journal of Thrombosis and Haemostasis×4
- Brandy R. Matthews
Medicine · Indiana University
- Anne M. Fagan
Medicine · Indiana University
- Andrew J. Saykin
Medicine · Indiana University
- Ann Marie Hake
Medicine · Indiana University
- Daniel Silverman
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile